← Leaderboards
Patricia A Ernst
Dartmouth College
$10,607,492
Attributed
$11,914,872
Total exposure
12
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,914,872 · 12
By mechanism
R01$9,592,799 · 5
R21$848,244 · 2
K01$646,380 · 1
P20$547,904 · 3
P30$279,545 · 1
Top collaborators
- Terry J. Fry5 shared
- David Bryder1 shared
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsLeukemiaMolecularPathway InteractionsAdultSelf-RenewalGeneticResearch PersonnelHematopoiesisIn VivoCell TypeHematopoietic Stem CellsProgramsMll GeneBiological ModelsMalignant NeoplasmsAnimal ModelStem CellsBone MarrowProgenitorInterestGenesMutantProteins
Grant awards (48)
Escape from CAR T surveillance through lineage plasticity$557,374
R01 · FY2025 · CA · contact PI
Escape from CAR T surveillance through lineage plasticity$535,637
R01 · FY2024 · CA · contact PI
Defining and predicting features of lineage-switch potential in KMT2A-r B-ALL using barcoding$156,000
R01 · FY2024 · CA · contact PI
Escape from CAR T surveillance through lineage plasticity$560,773
R01 · FY2023 · CA · contact PI
Escape from CAR T surveillance through lineage plasticity$578,670
R01 · FY2022 · CA · contact PI
MLL Family Histone Methyltransferases in Myeloid Leukemia$401,328
R01 · FY2022 · CA · contact PI
MLL Family Histone Methyltransferases in Myeloid Leukemia$415,663
R01 · FY2021 · CA · contact PI
Enhancing hematopoiesis through modulation of a histone methyltransferase: evaluating a new MLL1 gain-of-function animal model$279,900
R01 · FY2021 · DK · contact PI
MLL Family Histone Methyltransferases in Myeloid Leukemia$462,797
R01 · FY2020 · CA · contact PI
Enhancing hematopoiesis through modulation of a histone methyltransferase: evaluating a new MLL1 gain-of-function animal model$279,900
R01 · FY2020 · DK · contact PI
MLL Family Histone Methyltransferases in Myeloid Leukemia$397,815
R01 · FY2019 · CA · contact PI
Enhancing hematopoiesis through modulation of a histone methyltransferase: evaluating a new MLL1 gain-of-function animal model$279,900
R01 · FY2019 · DK · contact PI
MLL Family Histone Methyltransferases in Myeloid Leukemia$424,527
R01 · FY2018 · CA · contact PI
Connecting Epigenetic Regulator MLL1 to ERK and Survival Signaling in B cells$189,333
R21 · FY2018 · AI · contact PI
Cancer Mechanisms (CM)$64,598
P30 · FY2018 · CA · contact PI
Cancer Mechanisms (CM)$6,057
P30 · FY2018 · CA · contact PI
Cancer Mechanisms (CM)$5,342
P30 · FY2018 · CA · contact PI
Cancer Mechanisms (CM)$4,790
P30 · FY2018 · CA · contact PI
Cancer Mechanisms (CM)$3,213
P30 · FY2018 · CA · contact PI
Cancer Mechanisms (CM)$1,666
P30 · FY2018 · CA · contact PI
Connecting Epigenetic Regulator MLL1 to ERK and Survival Signaling in B cells$228,355
R21 · FY2017 · AI · contact PI
Cancer Mechanisms (CM)$66,515
P30 · FY2017 · CA · contact PI
Cancer Mechanisms (CM)$1,004
P30 · FY2017 · CA · contact PI
Cancer Mechanisms (CM)$64,370
P30 · FY2016 · CA · contact PI
MLL Function in the Maintenance of the Blood Forming System$382,918
R01 · FY2015 · HL · contact PI
Modeling hematologic malignancy and self-renewal with gain-of-function MLL1$226,306
R21 · FY2015 · OD · contact PI
Cancer Mechanisms (CM)$61,990
P30 · FY2015 · CA · contact PI
MLL Function in the Maintenance of the Blood Forming System$380,975
R01 · FY2014 · HL · contact PI
Modeling hematologic malignancy and self-renewal with gain-of-function MLL1$204,250
R21 · FY2014 · OD · contact PI
MLL Function in the Maintenance of the Blood Forming System$15,925
R01 · FY2014 · HL · contact PI
MLL Function in the Maintenance of the Blood Forming System$385,560
R01 · FY2013 · HL · contact PI
MLL Function in the Maintenance of the Blood Forming System$402,500
R01 · FY2012 · HL · contact PI
MLL Function in the Maintenance of the Blood Forming System$399,750
R01 · FY2011 · HL · contact PI
MLL Function in the Maintenance of the Blood Forming System$399,750
R01 · FY2010 · HL · contact PI
MLL Function in the Maintenance of the Blood Forming System$399,750
R01 · FY2009 · HL · contact PI
MLL Function in the Maintenance of the Blood Forming System$233,375
R01 · FY2009 · HL · contact PI
ROLE OF THE CHROMATIN REGULATOR, MLL, IN T CELL DEVELOPMENT$79,951
P20 · FY2009 · RR · contact PI
MLL Function in the Maintenance of the Blood Forming System$399,750
R01 · FY2008 · HL · contact PI
ROLE OF THE CHROMATIN REGULATOR, MLL, IN T CELL DEVELOPMENT$235,061
P20 · FY2008 · RR · contact PI
MII Regulation of Hematopoiesis$100,980
K01 · FY2008 · DK · contact PI
Runx1 as a Marker for Stem Sells$462,512
R01 · FY2007 · AI · contact PI
MLL Function in the Maintenance of the Blood Forming System$399,750
R01 · FY2007 · HL · contact PI
ROLE OF THE CHROMATIN REGULATOR, MLL, IN T CELL DEVELOPMENT$232,892
P20 · FY2007 · RR · contact PI
MII Regulation of Hematopoiesis$137,970
K01 · FY2007 · DK · contact PI
MII Regulation of Hematopoiesis$137,970
K01 · FY2006 · DK · contact PI
MII Regulation of Hematopoiesis$137,970
K01 · FY2005 · DK
MII Regulation of Hematopoiesis$76,016
K01 · FY2004 · DK
MII Regulation of Hematopoiesis$55,474
K01 · FY2004 · DK